Ali Ghufron Mukti
Department Of Public Health, Faculty Of Medicine, Public Health, And Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

Published : 13 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 13 Documents
Search

Financing of Dengue Hemorrhagic Fever Control Program in Banda Aceh City Ellia Nufara; Ali Ghufron Mukti; Tri Baskoro T. Satoto Mail
JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit) Vol. 7 No. 1 (2018): April 2018
Publisher : Universitas Muhammadiyah Yogyakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18196/jmmr.7153

Abstract

Background: From January to June 2017, the number of DHF cases in Banda Aceh City reached 216 cases with the incidence Rate of 89.5%. To suppress the increase in the cases, the Health Office of Banda Aceh and its staff has conducted control activities, but the number of DHF cases is difficult to reduce. It is therefore necessary to conduct this study to assess the relationship between the availability of DHF control programs and the number of DHF cases in Banda Aceh City. Methods: This observational was done using a case-control study design. The number of samples was 76 cases in four selected health centers with a case-control ratio of 1:1. For data collection, it was conducted in July until August 2017. Results: The results show that the reduction in funding of DHF disease control programs was associated with an increase in the number of DHF cases in Banda Aceh City (p = 0.005, OR = 2.49 at 95% CI; 1.23 - 5.06). Conclusion: Inadequate financing can increase the number of DHF cases in Banda Aceh City.
Dampak Biaya Laboratorium Terhadap Kesenjangan Tarif INA-CBGs dan Biaya Riil Diagnosis Leukemia Indriani, Diah; Kusnanto, Hari; Mukti, Ali Ghufron; Kuntoro, Kuntoro
Kesmas Vol. 7, No. 10
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Selama penerapan Diagnosis Related Group di Rumah Sakit Umum Pusat (RSUP) Dr. Sardjito, terjadi kesenjangan tarif biaya riil pelayanan kesehatan dengan tarif Indonesia Case Base Groups (INA-CBGs). Penyebab terbesar kesenjangan tarif tersebut adalah pelayanan obat dan penggunaan sumber daya laboratorium yang tidak efisien. Biaya pelayanan penunjang medis untuk pasien leukemia limfoblastik akut adalah sekitar 23,8% dari total biaya pelayanan kesehatan. Penelitian ini bertujuan untuk mengetahui tingkat efisiensi penggunan sumber daya laboratorium dan pengaruh terhadap kesenjangan tarif. Penelitian ini menganalisis semua rekam medis dan data biaya pelayanan laboratorium pasien leukemia limfoblastik akut tahun 2009-2010 di RSUP Dr. Sardjito Yogyakarta. Pemeriksaan kimia klinik menunjukkan pola pasien yang semakin parah, proporsi biaya pemeriksaan kimia klinik semakin rendah. Kondisi ini juga terjadi pada pemeriksaan radiologi, urine dan tinja rutin. Sementara pada pemeriksaan hematologi, mikrobiologi, dan imunologi/serologi menunjukkan pola semakin parah pasien maka semakin tinggi proporsi biaya pemeriksaan. Analisis regresi menemukan pemeriksaan kimia klinik meliputi mikrobiologi darah, ureum, magnesium, creatine kinase MB (blood) menyebabkan kesenjangan tarif semakin meningkat atau rumah sakit semakin dirugikan. Model regresi linier ini mempunyai nilai R2 sebesar 0,834 dengan nilai F = 84,475 (P < 0,05). Ketidakefisienan penggunaan sumber daya laboratorium pada pemeriksaan kimia klinik terdapat pada kelompok pasien tingkat keparahan ringan. Problems occurred during the implementation of Diagnosis Related Group in Sardjito Hospital Yogyakarta. There was gap price between the real cost of health care and Indonesia Case Base Groups (INA-CBGs) cost. The cause of the gap price was drug delivery and use of laboratory resources inefficiently. Cost of medical support services for acute lymphoblactic leukemia patients about 23.8% of the total cost of health care. This study aimed to analyze efficiency of the use of laboratory resources and their effect to discrepancy of price. This study analyzed all medical records and laboratory services cost data in 2009-2010 acute lymphoblastic leukemia patients at Sardjito Hospital Yogyakarta. Clinical chemistry test showed a pattern of more severe patients, the lower the percentage of clinical chemistry fees. This condition also occurs in radiological, urine test, and stool. While the test of hematology, microbiology and immunology/serology showed a pattern, the more severe the patient, the higher the percentage of the cost of the test. The results of the regression analysis showed that the more higher cost of clinical chemistry test (blood microbiology, urea, magnesium, creatine kinase MB (blood)) the higher discrepanct of price which causes the hospital getting harmed. Linear regression model has a value of determination coeficient 0.834 with a value of F = 84.475 (P < 0.05). Inefficiency of resource use in the test of clinical chemistry laboratory located on the mild severity of the patient group.
Discrepancies in Hospital Cost and Indonesia's Case-based Groups: A Literature Review Skarayadi, Oskar; Endarti, Dwi; Satibi, Satibi; Mukti, Ali Ghufron
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 15, No 4
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.95970

Abstract

Background: Indonesia started establishing national health insurance in 2014. Implementation of Indonesian national health insurance has frequent gaps between health expenditures based on hospital tariffs and the INA-CBG tariffObjectives: This review was aimed to compare the hospital tariff of healthcare to the INA-CBGs tariff and to identify the factors contributing to the actual cost.Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology followed in this research. The keywords "Real Cost and INA CBG'S" were used in Google Scholar, and the keywords "INA CBG'S AND REAL COST" on Pubmed, ScienceDirect, and Scopus between 2014 and 2022.Results: A total of 634 records were found through database searching of Google Scholar (594), Pubmed (1), ScienceDirect (36), and Scopus (3). After the screening process, 24 articles were included in the review. It was found that 13 articles (54.16%) showed a lower hospital tariff than INA CBG's tariff, while 11 articles (45.84%) showed a higher hospital tariff than INA CBG's tariff. The main factors affecting the gaps of hospital tariff versus INA CBGs tariff mentioned in the articles were LOS, severity, and hospitality class.Conclusion: The literature of this review found hospital rates are higher with rates of INA-CBGs in many hospitals, so it requires a review of rates and an efficient strategy of hospitals.